Literature DB >> 35986782

Are the use of fluoroquinolones in prostate biopsy prophylaxis returning? Comment on "antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study".

Erdem Kisa1.   

Abstract

Entities:  

Year:  2022        PMID： 35986782     DOI： 10.1007/s00345-022-04113-0

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   3.661


× No keyword cloud information.
  2 in total

1.  Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.

Authors:  Michael A Liss; Stephen A Taylor; Deepak Batura; Deborah Steensels; Methee Chayakulkeeree; Charlotte Soenens; G Gopal Rao; Atreya Dash; Samuel Park; Nishant Patel; Jason Woo; Michelle McDonald; Unwanaobong Nseyo; Pooya Banapour; Stephen Unterberg; Thomas E Ahlering; Hendrik Van Poppel; Kyoko Sakamoto; Joshua Fierer; Peter C Black
Journal:  J Urol       Date:  2014-06-10       Impact factor: 7.450

2.  Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors.

Authors:  Erdem Kisa; Mustafa Ugur Altug; Oguz Alp Gurbuz; Harun Ozdemir
Journal:  Int Braz J Urol       Date:  2017 Nov-Dec       Impact factor: 1.541
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.